Biora Therapeutics Home
Activate the mobile navigation
Close the mobile navigation
Close
Home
Company
About
Leadership
Careers
Pipeline
Development Pipeline
Targeted Therapeutics
Systemic Therapeutics
Publications
Investors
Investor Overview
Press Releases
Events & Presentations
SEC Filings
Annual & Quarterly Reports
Stock Quote & Chart
Historical Price Lookup
Analyst Coverage
Governance Documents
Committee Composition
Investor FAQs
Investor Email Alerts
Investor Relations Contact
Contact
Toggle the search bar
Search the Site
Close the mobile navigation
Publications
Select Category
Select Category...
Gastrointestinal Health
Systemic Therapeutics
Targeted Therapeutics
Evaluation of the pharmacokinetics of glucagon-like-peptide-1 (GLP-1) receptor agonist delivered through the BioJetâ„¢ oral biotherapeutic delivery platform in a porcine model
June 23, 2023
#Systemic Therapeutics
Potential effects of food on a novel Drug Delivery System (DDS) to deliver therapeutic compound into the colon
January 19, 2023
#Targeted Therapeutics
Development of a novel Drug Delivery System (DDS) to deliver drugs directly to the colonic mucosa to improve efficacy and reduce systemic exposure for the treatment of ulcerative colitis (UC)
January 19, 2023
#Targeted Therapeutics
A scintigraphic study to evaluate the localization and delivery function of a Drug Delivery System (DDS) device in patients with active ulcerative colitis in fasted state
October 23, 2022
#Targeted Therapeutics
A scintigraphic study to evaluate the safety, tolerability, and functionality of a Drug Delivery System (DDS) device in healthy volunteers in fasted state
October 23, 2022
#Targeted Therapeutics
Pilot study to assess pharmacokinetic and pharmacodynamic markers following enema-dosing with adalimumab in patients with active ulcerative colitis
October 23, 2022
#Targeted Therapeutics
Evaluation of the pharmacokinetics of PGN-OB1 following oral administration of an oral biotherapeutics delivery system (OBDS) in Yucatan swine
October 23, 2022
#Systemic Therapeutics
Development of ex-vivo and in-vivo models to assess the performance of an oral biotherapeutic delivery system (OBDS) capsule
October 23, 2022
#Systemic Therapeutics
Development of preclinical models to assess the performance of the oral biotherapeutic delivery system (OBDS) capsule
October 18, 2022
#Systemic Therapeutics
1
2
3
Connect with us
Email Us
Biora Therapeutics Linkedin
Biora Therapeutics Twitter